CD27 and neoplasm: Similarly, the frequency of tumour-infiltrating CD3+CD8+CD27+ T cells were significantly lower post-CROSS chemoradiation compared with the treatment-naïve setting (16.8 ± 3.1 vs. 4.64 ± 1.9%, p = 0.03), (Fig. 5).